Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher McCabe
Mike Paulden
Isaac Awotwe
Andrew Sutton
Peter Hall

PharmacoEconomics

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics|December 17, 2019
One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net BenefitChristopher McCabe, Mike Paulden, Isaac Awotwe, et al.
Pharmacoeconomics|November 23, 2020
Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit FrontierChristopher McCabe, Giovanni Tramonti, Andrew Sutton, et al.
Pharmacoeconomics|January 31, 2021
Modifying NICE's Approach to Equity WeightingMike Paulden, Christopher McCabe
Pharmacoeconomics|December 13, 2016
Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and MedicineMike Paulden, James F O'Mahony, Christopher McCabe
Pharmacoeconomics|November 22, 2014
Value-based reimbursement decisions for orphan drugs: a scoping review and decision frameworkMike Paulden, Tania Stafinski, Devidas Menon, et al.
Pharmacoeconomics|May 11, 2017
A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness ModelsChase Hollman, Mike Paulden, Petros Pechlivanoglou, et al.
Pharmacoeconomics|August 23, 2014
Some inconsistencies in NICE's consideration of social valuesMike Paulden, James F O'Mahony, Anthony J Culyer, et al.
Pharmacoeconomics|August 20, 2020
Correction to: Calculating and Interpreting ICERs and Net BenefitMike Paulden
Pharmacoeconomics|March 18, 2026
A Modern Approach for Constructing Decision Analytic Models in Microsoft ExcelMike Paulden
Pharmacoeconomics|May 12, 2020
Calculating and Interpreting ICERs and Net BenefitMike Paulden
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|December 17, 2019
One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net BenefitChristopher McCabe, Mike Paulden, Isaac Awotwe, et al.
Pharmacoeconomics|November 23, 2020
Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit FrontierChristopher McCabe, Giovanni Tramonti, Andrew Sutton, et al.
Pharmacoeconomics|January 31, 2021
Modifying NICE's Approach to Equity WeightingMike Paulden, Christopher McCabe
Pharmacoeconomics|December 13, 2016
Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and MedicineMike Paulden, James F O'Mahony, Christopher McCabe
Pharmacoeconomics|November 22, 2014
Value-based reimbursement decisions for orphan drugs: a scoping review and decision frameworkMike Paulden, Tania Stafinski, Devidas Menon, et al.
Pharmacoeconomics|May 11, 2017
A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness ModelsChase Hollman, Mike Paulden, Petros Pechlivanoglou, et al.
Pharmacoeconomics|August 23, 2014
Some inconsistencies in NICE's consideration of social valuesMike Paulden, James F O'Mahony, Anthony J Culyer, et al.
Pharmacoeconomics|August 20, 2020
Correction to: Calculating and Interpreting ICERs and Net BenefitMike Paulden
Pharmacoeconomics|March 18, 2026
A Modern Approach for Constructing Decision Analytic Models in Microsoft ExcelMike Paulden
Pharmacoeconomics|May 12, 2020
Calculating and Interpreting ICERs and Net BenefitMike Paulden
Pageof 3